Litcius/Paper detail

Activation of Hippo signaling pathway mediates mitochondria dysfunction and dilated cardiomyopathy in mice

Wei Wu, Mark Ziemann, Kevin Huynh, Gang She, Zheng‐Da Pang, Yi Zhang, Thy Duong, Helen Kiriazis, Tian-Tian Pu, Ru‐Yue Bai, Jingjing Li, Yu Zhang, Mingxia Chen, Junichi Sadoshima, Xiu‐Ling Deng, Peter J. Meikle, Xiao‐Jun Du

2021Theranostics93 citationsDOIOpen Access PDF

Abstract

Hippo signaling activation mediates mitochondrial damage by repressing mitochondrial genes, which causally promotes the development of DCM. The Hippo pathway therefore represents a therapeutic target against mitochondrial dysfunction in cardiomyopathy.

Topics & Concepts

Hippo signaling pathwayMitochondrionCardiolipinBiologyCell biologyOxidative phosphorylationMitochondrial DNATranscription factorGeneSignal transductionBiochemistryMembranePhospholipidHippo pathway signaling and YAP/TAZRNA Research and Splicing
Activation of Hippo signaling pathway mediates mitochondria dysfunction and dilated cardiomyopathy in mice | Litcius